Richard I Eisenstadt - Net Worth and Insider Trading
Richard I Eisenstadt Net Worth
The estimated net worth of Richard I Eisenstadt is at least $208,622 dollars as of 2024-04-27. Richard I Eisenstadt is the CFO of Altimmune Inc and owns about 22,010 shares of Altimmune Inc (ALT) stock worth over $159,793. Richard I Eisenstadt is also the CFO of Neos Therapeutics Inc and owns about 42,460 shares of Neos Therapeutics Inc (NEOS) stock worth over $48,829. Details can be seen in Richard I Eisenstadt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Richard I Eisenstadt has not made any transactions after 2023-03-24 and currently still holds the listed stock(s).
Transaction Summary of Richard I Eisenstadt
Richard I Eisenstadt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard I Eisenstadt owns 4 companies in total, including Neos Therapeutics Inc (NEOS) , Ocera Therapeutics Inc (OCRX) , and Altimmune Inc (ALT) among others .
Click here to see the complete history of Richard I Eisenstadt’s form 4 insider trades.
Insider Ownership Summary of Richard I Eisenstadt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NEOS | Neos Therapeutics Inc | 2020-03-02 | Chief Financial Officer |
| OCRX | Ocera Therapeutics Inc | 2012-08-07 | VP & Finance & CFO |
| ALT | Altimmune Inc | 2023-03-24 | Chief Financial Officer |
| AYTU | Aytu BioPharma Inc | 2021-03-31 | Chief Financial Officer |
Richard I Eisenstadt Latest Holdings Summary
Richard I Eisenstadt currently owns a total of 2 stocks. Among these stocks, Richard I Eisenstadt owns 22,010 shares of Altimmune Inc (ALT) as of March 24, 2023, with a value of $159,793 and a weighting of 76.59%. Richard I Eisenstadt also owns 42,460 shares of Neos Therapeutics Inc (NEOS) as of December 12, 2018, with a value of $48,829 and a weighting of 23.41%.
Latest Holdings of Richard I Eisenstadt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALT | Altimmune Inc | 2023-03-24 | 22,010 | 7.26 | 159,793 |
| NEOS | Neos Therapeutics Inc | 2018-12-12 | 42,460 | 1.15 | 48,829 |
Holding Weightings of Richard I Eisenstadt
Richard I Eisenstadt Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard I Eisenstadt has made a total of 1 transactions in Altimmune Inc (ALT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Altimmune Inc is the acquisition of 10,000 shares on March 24, 2023, which cost Richard I Eisenstadt around $43,100.
According to the SEC Form 4 filings, Richard I Eisenstadt has made a total of 0 transactions in Neos Therapeutics Inc (NEOS) over the past 5 years. The most-recent trade in Neos Therapeutics Inc is the acquisition of 5,000 shares on December 12, 2018, which cost Richard I Eisenstadt around $10,800.
Insider Trading History of Richard I Eisenstadt
- 1
Richard I Eisenstadt Trading Performance
GuruFocus tracks the stock performance after each of Richard I Eisenstadt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard I Eisenstadt is 1.9%. GuruFocus also compares Richard I Eisenstadt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard I Eisenstadt within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard I Eisenstadt's insider trading performs compared to the benchmark.
Performance of Richard I Eisenstadt
Average Return
31.58%
Outperforming Transactions
67%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.82 | 1.9 | -27.78 | 31.58 | -26.64 | -35.12 |
| Relative Return to S&P 500(%) | 16.24 | -3.66 | -36.58 | 10.32 | -42.94 | -44.57 |
Richard I Eisenstadt Ownership Network
Ownership Network List of Richard I Eisenstadt
Ownership Network Relation of Richard I Eisenstadt
Richard I Eisenstadt Owned Company Details
What does Neos Therapeutics Inc do?
Who are the key executives at Neos Therapeutics Inc?
Richard I Eisenstadt is the Chief Financial Officer of Neos Therapeutics Inc. Other key executives at Neos Therapeutics Inc include director & Chief Executive Officer Gerald W. Mclaughlin , SVP & General Counsel John M Limongelli , and Chief Commercial Officer Thomas P Mcdonnell .
Neos Therapeutics Inc (NEOS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neos Therapeutics Inc Insider Transactions
Richard I Eisenstadt Mailing Address
Above is the net worth, insider trading, and ownership report for Richard I Eisenstadt. You might contact Richard I Eisenstadt via mailing address: 4819 Emperor Boulevard, Suite 400, Durham Nc 27703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
